- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$471.5 MnMarket Estimate, 2026
$501.2 MnMarket Forecast, 2034
$817.2 MnCAGR, 2026–2034
6.3%Global Riboflavin Market Size, Growth, Trends & Forecast (2026–2034)
The global riboflavin (Vitamin B2) market size was valued at USD 471.56 million in 2025, is estimated to reach USD 501.27 million in 2026, and is projected to scale up to USD 817.22 million by 2034, registering a compound annual growth rate (CAGR) of 6.3% during the forecast period from 2026 to 2034. Driven by increasing health awareness, a rise in deficiency disorders, and expanding applications across food fortification, animal nutrition, and pharmaceuticals, the market continues to experience steady upward momentum worldwide.
Key Executive Metrics (At-a-Glance)
- 2025 Base Valuation: USD 471.56 Million
- 2026 Current Valuation: USD 501.27 Million
- 2034 Forecast Valuation: USD 817.22 Million
- Compound Annual Growth Rate (CAGR): 6.3% (2026–2034)
- Dominant Regional Market: North America (retaining a leading position backed by high consumer health awareness, advanced tech innovations, and urban per capita spending)
- Key Growth Segments: Powder formulation and dietary supplements/animal feed applications maintain major market volume, while pharmaceutical applications expand rapidly.
Core Market Drivers & Opportunities
- Nutritional Fortification & Supplements: Rising consumption of vitamin-infused dietary supplements, functional foods, and beverages to combat nutritional deficiencies.
- Animal Feed Expansion: Extensive utilization of riboflavin as an essential growth stimulator and metabolic enhancer in livestock and poultry production.
Primary Market Restraints & Challenges
- Cost & Processing Barriers: High pricing associated with heavily fortified functional products and vitamin loss during intense food processing stages.
- Regulatory & Alternative Constraints: Strict governmental restrictions and competition from alternative dietary food sources.
Global Riboflavin Market Segmentation Breakdown
| Segment Category | Largest Segment / Leader | Fastest-Growing Segment |
|---|---|---|
| By Form | Powder (Dominates volume share owing to high stability and broad use in dry blends and feeds) | Liquid (Gaining momentum due to easy integration into functional beverages and syrups) |
| By Application | Animal Feed / Dietary Supplements (Leading volume consumption for livestock health and human nutrition) | Pharmaceuticals (Expands fastest on therapeutic formulations, metabolic disorder treatments, and R&D) |
| By Source | Plant / Fermentation-Derived (Captures the lion's share via industrial microbial fermentation synthesis) | Advanced Synthetic / Bio-engineered variants (Scaling to meet strict purity benchmarks) |
| By Region | North America (Established leadership driven by high health awareness and per capita spending) | Asia-Pacific (Fastest-growing hub fueled by rising disposable incomes, urbanization, and expanding production in China/Japan) |
Major Industry Players Profiled
Key market leaders shaping the global riboflavin landscape include DSM, Hegno, Xinfa Pharmaceutical, Ningxia Qiyuan Pharmaceutical, NB Group, Shanxi Jixiang Biological Engineering, Acebright Pharmaceuticals Group, Hubei Guangji Pharmaceutical, and BASF SE.
Global Riboflavin Market Size
The global riboflavin market size was valued at USD 471.56 million in 2025 and is expected to reach USD 817.22 million by 2034 from USD 501.27 million in 2026, growing at a CAGR of 6.3%
MARKET OVERVIEW
Riboflavin is also known as vitamin B2 and is an essential vitamin, commonly found in various food sources and necessary for the body's nutrition. Riboflavin is used as a dietary supplement and is found in food products such as eggs, green leafy vegetables, milk and dairy products, legumes, lean meats, mushrooms, almonds, and others. It is a water-soluble vitamin and necessary for the growth, development and function of cells. The daily requirement for riboflavin is based on age and gender as stated by the National Academy of Medicine in Recommended Food Intakes. A shortage of riboflavin in the diet can lead to a riboflavin deficiency known as ariboflavinosis, which results in a sore throat, cheilosis, and inflammation of the mouth, skin rashes, anemia, and liver and liver degeneration nervous system. Riboflavin is extracted from food sources or chemically synthesized for commercial production used for animal feed and food fortification.
MARKET DRIVERS AND RESTRAINTS
The global riboflavin market is driven by increased demand for riboflavin infused supplements due to its multiple utility, making it widely used in all market sectors around the world. Riboflavin is consumed through medications due to increased vitamin deficiencies in most adults and infants. Additionally, riboflavin is used in various processed foods as a coloring and fortifying agent, as well as in foods. Riboflavin also plays an important role in the feed industry as a growth stimulator. As riboflavin is high in collagen, it is used to nourish skin and hair, which is why it is promoted in cosmetics. Increased health awareness, need for a healthy diet, increased riboflavin deficiency disorders, increased malnutrition, advanced innovation and technology, industrial synthesis of riboflavin, intensive use of riboflavin for fortification, widespread diseases, development of new products, investment in R&D, recommended dietary intake, lack of natural food sources, the rapid increase in dietary supplements, widespread use for medicinal purposes, fortification of personal care products by riboflavin, use in animal feed, availability of liquid riboflavin extracts, vitamin B2 capsules, excellent urbanization and increased disposable income are the main drivers of the growth of the global riboflavin market. However, high-priced fortified foods, traditional beliefs, loss of vitamins during processing, government restrictions, and availability of alternative food products are hampering this business growth.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| CAGR | 6.3% |
| Segments Covered | By Form, Application, Source, and Region |
| Various Analyses Covered | Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
| Regions Covered | North America, Europe, APAC, Latin America, Middle East & Africa |
| Market Leaders Profiled | DSM, Hegno, Xinfa Pharmaceutical, Ningxia Qiyuan Pharmaceutical, NB Group, Shanxi Jixiang Biological Engineering, Acebright Pharmaceuticals Group, Hubei Guangji Pharmaceutical, BASF SE and Others. |
REGIONAL ANALYSIS
North America continues the leading position in the riboflavin market, due to technological innovations, product development, industrialization, and rapid urbanization. In addition, increased awareness among consumers related to health, surge in per capita spending, and various applications are supporting the growth of the riboflavin business in the US marketplace. The increasing concerns about vitamin deficiency in western diets, especially among the elderly are providing impetus to the local market. Milk and dairy products enriched with vitamin B2 are essential in the enriched food market in North America, which will likely fuel the general need.
In Europe and Asia-Pacific, riboflavin is mainly consumed in supplement form, as many people suffer from vitamin deficiencies and increased liver abnormalities. In Japan, riboflavin is also used in pharmaceuticals and cosmetics due to increased exports. In the Middle East and Africa, riboflavin is used for chemical synthesis and for pharmaceutical purposes. Due to increasing demand and distribution, the growth of the global riboflavin market is expected to remain positive during the forecast period.
KEY PLAYERS IN THE GLOBAL RIBOFLAVIN MARKET
Major Key Players in the Global Riboflavin Market are Hegno, DSM, Xinfa Pharmaceutical, Ningxia Qiyuan Pharmaceutical, NB Group, Shanxi Jixiang Biological Engineering, Acebright Pharmaceuticals Group, Hubei Guangji Pharmaceutical, BASF, and others.
RECENT HAPPENINGS IN THE MARKET
- In September 2017, Eisai Co., Ltd. announced that it has launched the vitamin B2 tablet “Chocola BB® Plus” (general food product, Chinese name :), a major product of the Chocola BB series, in Taiwan. This is the first launch of this product in an Asian region outside of Japan. From this launch, Eisai intends to expand this product to the Asian market. Products such as Chocola BB® Royal Drink have also been marketed in Taiwan and many Taiwanese consumers are familiar with the Chocola BB brand.
- The company called "Vitabiotics" which is a vitamin and health supplement, has plans to launch three of its main OTC brands which are Perfectil, Wellwomen, and Wellman, in India in 2020. The company positions these brands as lifestyle products for young health-conscious Indians.
- Perfectil, a renowned beauty vitamin company based in the UK, started its sales in Walgreens stores in the US. Perfectil, by Vitabiotics is a complete multivitamin and beauty supplement with specific formulations designed to support the skin, hair or hair nail. Each formulation contains between 22 and 28 bioactive micronutrients that help deliver radiant beauty from within.
MARKET SEGMENTATION
This research report on the global riboflavin market has been segmented and sub-segmented based on form, application, source, and region.
By Form
- Liquid
- Powder
By Application
- Personal Care
- Animal Feed
- Pharmaceuticals
- Dietary Supplements
- Food and Beverages
By Source
- Animal
- Plant
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- The Middle East and Africa